Heranba Industries Limited has launched two innovative crop nutrition products, Fentaamine and MycoHil, on April 10, 2026, marking its strategic entry into the rapidly expanding crop nutrition segment. The company announced ambitious revenue targets of ₹2,500 crore for the current fiscal year from its combined crop protection and crop nutrition segments.

Product Launch Details

The company introduced these breakthrough products at a grand launch event held at Leonia Holistic Destination in Hyderabad. Both products fall under the category of innovative crop nutrition solutions and are initially targeted at the domestic market.

Product Specifications and Benefits

Fentaamine is positioned as a next-generation bio stimulant engineered to enhance plant metabolism, improve stress tolerance, and boost crop yield. The product focuses on optimizing plant physiological processes to deliver improved agricultural outcomes.

MycoHil serves as an advanced biofertilizer designed to improve nutrient absorption, strengthen soil microbiology, and promote sustainable agriculture practices. This product emphasizes soil health enhancement and sustainable farming methodologies.

Both products have been developed through collaboration with a leading American multinational company, combining global research expertise with Heranba Industries' robust manufacturing capabilities.

Strategic Vision and Growth Targets

The company's entry into crop nutrition aligns with its Vision 2026 growth roadmap. Managing Director R. K. Shetty highlighted that the crop nutrition segment is witnessing strong growth with a CAGR of over 15% globally and in India, making it a natural strategic progression for the company.

Capability Enhancement Initiatives

To support its expansion strategy, Heranba Industries Limited is investing in multiple areas including talent acquisition and capability building, strengthening sales and marketing infrastructure, enhancing last-mile farmer engagement, channel partners engagement, and expanding global business operations.

The company operates as a leading manufacturer of synthetic pyrethroids and intermediates with a strong presence across the agrochemical value chain, from technicals to formulations. This latest product launch represents a significant milestone in the company's commitment to improving crop productivity and supporting global food security through innovative agricultural solutions.

Heranba Industries has issued a clarification regarding an inadvertent error in its earlier regulatory filing about the resignation of a senior management personnel. The company corrected the name of the resigned General Manager-Works from Mr. Manoj Kenjale to the correct name Mr. Mahesh Kenjale, while confirming that all other details remain unchanged.

Name Correction Details

The clarification was submitted to BSE Limited on April 09, 2026, addressing the typographical error in the original intimation letter dated the same day. The company acknowledged that due to a clerical mistake, the wrong name was mentioned in the initial regulatory disclosure.

Regulatory Compliance

The company emphasized that all other details including designation, reason for resignation, and effective date of resignation remain unchanged and correct as per the earlier disclosure. Heranba Industries noted that the XBRL filing submitted with the exchange contains the correct name of the senior management personnel.

Company Statement

In the clarification letter signed by Abdul Latif, Company Secretary & Compliance Officer, the company expressed regret for the inconvenience caused due to this unintentional error. The filing was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Updated Resignation Information

Mr. Mahesh Kenjale will cease to be part of the company's senior management team at the close of business hours on April 30, 2026. According to the original resignation details, he is leaving his position to pursue better opportunities and has committed to ensuring a smooth transition during his notice period.

Corporate Details

Heranba Industries Limited, with CIN No.L24231GJ1992PLC017315, has its corporate office located at 2nd Floor, A Wing, Fortune Avirahi, Jambli Galli, Jain Derasar Road, Borivali (W), Mumbai - 400092. The company trades on BSE with scrip code 543266.